Mouse vanin-1 is cytoprotective for islet beta cells and regulates the development of type 1 diabetes

Diabetologia

Volumn 51, Issue 7, 2008, Pages 1192-1201

  Roisin Bouffay, C ^a,b,c   Castellano, R ^a,b,c   Valero R ^d   Chasson, L ^a,b,c   Galland, F ^a,b,c   Naquet, P ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS UMR6102   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Cystamine; Cytoprotection; Islet beta cells; Pantetheinase; Type 1 diabetes

Indexed keywords

AMIDASE; CYSTAMINE; STREPTOZOCIN; VANIN 1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTE TRANSFER; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

EID: 44749094011     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-008-1017-9     Document Type: Article

References (48)

1. You S, Belghith M, Cobbold S et al (2005) Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T cells. Diabetes 54:1415-1422
2. Taubert R, Schwendemann J, Kyewski B (2007) Highly variable expression of tissue-restricted self-antigens in human thymus: implications for self-tolerance and autoimmunity. Eur J Immunol 37:838-848
3. Vafiadis P, Bennett ST, Todd JA et al (1997) Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15:289-292
4. Kishimoto H, Sprent J (2001) A defect in central tolerance in NOD mice. Nat Immunol 2:1025-1031
5. Yoon JW, Jun HS (2006) Viruses cause type 1 diabetes in animals. Ann N Y Acad Sci 1079:138-146
6. Fujinami RS, von Herrath MG, Christen U, Whitton JL (2006) Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev 19:80-94
7. Andre I, Gonzalez A, Wang B, Katz J, Benoist C, Mathis D (1996) Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc Natl Acad Sci USA 93:2260-2263
8. Lee MS, Chang I, Kim S (2004) Death effectors of beta-cell apoptosis in type 1 diabetes. Mol Genet Metab 83:82-92
9. Mathis D, Vence L, Benoist C (2001) Beta-cell death during progression to diabetes. Nature 414:792-798
10. Nitta Y, Kawamoto S, Tashiro F et al (2001) IL-12 plays a pathologic role at the inflammatory loci in the development of diabetes in NOD mice. J Autoimmun 16:97-104
11. Steer SA, Scarim AL, Chambers KT, Corbett JA (2006) Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med 3:e17
12. Chervonsky AV, Wang Y, Wong FS et al (1997) The role of Fas in autoimmune diabetes. Cell 89:17-24
13. Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P (2000) IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. J Clin Invest 105:459-468
14. Apostolou I, Hao Z, Rajewsky K, von Boehmer H (2003) Effective destruction of Fas-deficient insulin-producing beta cells in type 1 diabetes. J Exp Med 198:1103-1106
15. Trembleau S, Penna G, Gregori S et al (1999) Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J Immunol 163:2960-2968
16. Nikolic T, Geutskens SB, van Rooijen N, Drexhage HA, Leenen PJ (2005) Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study. Lab Invest 85:487-501
17. Martin AP, Alexander-Brett JM, Canasto-Chibuque C et al (2007) The chemokine binding protein m3 prevents diabetes induced by multiple low doses of streptozotocin. J Immunol 178:4623-4631
18. Haskins K, Bradley B, Powers K et al (2003) Oxidative stress in type 1 diabetes. Ann N Y Acad Sci 1005:43-54
19. Li X, Chen H, Epstein PN (2006) Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic β-cells. Diabetes 55:1592-1604
20. Bertera S, Crawford ML, Alexander AM et al (2003) Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. Diabetes 52:387-393
21. Hotta M, Tashiro F, Ikegami H et al (1998) Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med 188:1445-1451
22. Pitari G, Malergue F, Martin F et al (2000) Pantetheinase activity of membrane-bound Vanin-1: lack of free cysteamine in tissues of Vanin-1 deficient mice. FEBS Lett 483:149-154
23. -/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress. Mol Cell Biol 24:7214-7224
24. Martin F, Penet MF, Malergue F et al (2004) Vanin-1(-/-) mice show decreased NSAID- and schistosoma-induced intestinal inflammation associated with higher glutathione stores. J Clin Invest 113:591-597
25. Berruyer C, Pouyet L, Millet V et al (2006) Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. J Exp Med 203:2817-2827
26. Karpuj MV, Becher MW, Springer JE et al (2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. Nat Med 8:143-149
27. Borrell-Pages M, Canals JM, Cordelieres FP et al (2006) Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. J Clin Invest 116:1410-1424
28. Tremblay ME, Saint-Pierre M, Bourhis E, Levesque D, Rouillard C, Cicchetti F (2006) Neuroprotective effects of cystamine in aged Parkinsonian mice. Neurobiol Aging 27:862-870
29. Harada M, Makino S (1984) Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide. Diabetologia 27:604-606
30. McEvoy RC, Andersson J, Sandler S, Hellerstrom C (1984) Multiple low-dose streptozotocin-induced diabetes in the mouse. Evidence for stimulation of a cytotoxic cellular immune response against an insulin-producing beta cell line. J Clin Invest 74:715-722
31. Karges W, Hammond-McKibben D, Gaedigk R, Shibuya N, Cheung R, Dosch HM (1997) Loss of self-tolerance to ICA69 in nonobese diabetic mice. Diabetes 46:1548-1556
32. Bendelac A, Carnaud C, Boitard C, Bach JF (1987) Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+T cells. J Exp Med 166:823-832
33. Liadis N, Murakami K, Eweida M et al (2005) Caspase-3-dependent beta-cell apoptosis in the initiation of autoimmune diabetes mellitus. Mol Cell Biol 25:3620-3629
34. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279
35. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408
36. Gregori S, Giarratana N, Smiroldo S, Adorini L (2003) Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 171:4040-4047
37. Brode S, Raine T, Zaccone P, Cooke A (2006) Cyclophosphamide-induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 177:6603-6612
38. Nicolls MR, Haskins K, Flores SC (2007) Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal 9:879-889
39. Shoda LK, Young DL, Ramanujan S et al (2005) A comprehensive review of interventions in the NOD mouse and implications for translation. Immunity 23:115-126
40. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301-305
41. Lehrke M, Lazar MA (2005) The many faces of PPARgamma. Cell 123:993-999
42. Pantano C, Reynaert NL, van der Vliet A, Janssen-Heininger YM (2006) Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal 8:1791-1806
43. Eldor R, Yeffet A, Baum K et al (2006) Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents. Proc Natl Acad Sci U S A 103:5072-5077
44. Ientile R, Campisi A, Raciti G et al (2003) Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells. J Neurosci Res 74:52-59
45. Lesort M, Lee M, Tucholski J, Johnson GV (2003) Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders. J Biol Chem 278:3825-3830
46. Chu F, Koomen JM, Kobayashi R, O'Brian CA (2005) Identification of an inactivating cysteine switch in protein kinase Cepsilon, a rational target for the design of protein kinase Cepsilon-inhibitory cancer therapeutics. Cancer Res 65:10478-10485
47. Ivaska J, Bosca L, Parker PJ (2003) PKCepsilon is a permissive link in integrin-dependent IFN-gamma signalling that facilitates JAK phosphorylation of STAT1. Nat Cell Biol 5:363-369
48. Suk K, Kim S, Kim YH et al (2001) IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J Immunol 166:4481-4489